What also helped was the invention of a new sequencing technique by Frederick Sanger, a British biochemist at the University of Cambridge, which he used to crack the amino acid structure of insulin in 1955 (Marks 2015)
A medically supervised program can help determine whether treatment is appropriate, monitor progress, answer questions, review side effects, and adjust the plan when needed
Expanded Indications for GLP-1 Receptor Agonists The 2025 American Diabetes Association (ADA) Standards of Care have broadened the use of GLP-1 receptor agonists beyond glycemic control
For example, Wegovy is specifically FDA-approved for weight management in adults with obesity or overweight conditions
By end user, the hospitals segment held a 19% share of the market in 2025 and is expected to grow at a CAGR of 8.4% during the projection period